Anxiety Disorders are prevalent and often chronic, recurrent conditions that reduce quality of
life. The first-line treatments, such as serotonin reuptake inhibitors and cognitive behavioral …

Background Many low-and middle-income countries, including Latin America, lack access to
biomarkers for the diagnosis of prodromal Alzheimer's Disease (AD; mild cognitive …

Associations between cognitive decline and cerebral microbleeds (CMBs) have received
increasing attention. An association between CMB distribution (deep or lobar) and cognitive …

Although medial temporal atrophy (MTA) and parietal atrophy (Koedam score) have been
used to diagnose Alzheimer's disease (AD), early detection of other dementia types remains …

Background: Time and resource limitations prevent cognitive assessment in acute-to-
subacute settings, even in comprehensive stroke centers. Objective: To assess cognitive …

Background: Application of visual scoring scales for regional atrophy in Alzheimer's disease
(AD) in clinical settings is limited by their high time cost and low intra/inter-rater agreement …

The presence of amyloid-β (Aβ) deposition is considered important in patients with amnestic
mild cognitive impairment (aMCI), since they can progress to Alzheimer's disease dementia …

Untitled Page 1 Page 2 2 АНОТАЦІЯ Чиняк ОСДіагностична значущість деяких інтерлейкінів у
диференціальній діагностиці вікозалежних деменцій. – Кваліфікаційна наукова праця на …

Background: Many low-and middle-income countries, including Latin America, lack access
to biomarkers for the diagnosis of prodromal Alzheimer's Disease (AD; mild cognitive …